ArticleOncotarget2017

Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1.

Lingzhi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.